CD57+ expression in T lymphocytes has beenrecognized as a marker of in vitro replicative senescence and offunctional immune deficiency in patients with autoimmune disease, infectiousdiseases, and cancers (reviewed in Focosi et al. (24)). This evidence concerns the gene B3GAT1 and autoimmune disease.